Review of Hereditary Angioedema Management
Author Information
Author(s): Tom Bowen
Primary Institution: University of Calgary
Hypothesis
To review approaches for the diagnosis and management of hereditary angioedema (HAE) circa December 2010.
Conclusion
The study emphasizes the need for comprehensive care clinics and updated management algorithms for hereditary angioedema based on recent clinical trial data.
Supporting Evidence
- The study reviews multiple phase III clinical trials published on hereditary angioedema.
- Management approaches and models are discussed in light of new clinical trial data.
- Quality-of-life and cost affordability benefit conclusions will likely vary between countries.
Takeaway
This study looks at how to better manage a condition called hereditary angioedema, which causes swelling, by using new research and treatment options.
Methodology
PubMed searches including hereditary angioedema and diagnosis, therapy, management and consensus were reviewed.
Potential Biases
Potential conflicts of interest due to author affiliations with pharmaceutical companies.
Limitations
The study relies on existing literature and may not encompass all recent developments in HAE management.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website